Lilly(Eli) & Co XNYS: LLY

Expensive Performer

Download real time

839.96 105.06 (14.30%)

52W Low on Apr 07, 2025

10.8M XNYS Volume

High volume+gain today

XNYS 17 Apr, 2025 5:30 PM (EDT)

0.4

Beta 1Year

Very Low volatility

Positive Trial

Eli Lilly rises as its new diabetes drug, Orforglipron, shows positive phase-3 trial results See details

Lilly(Eli) & Co RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Lilly(Eli) & Co technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis